斯里兰卡登革热病毒血清型-2菌株的分子流行病学和进化特征
Dinuka Ariyaratne1, Tibutius Thanesh Pramanayagam Jayadas1, Chandima Jeewandara1
1University of Sri Jayewardenepura.
Research square
|July 18, 2025
概括
斯里兰卡的登革热病毒 (DENV) 监测显示,DENV-2基因型II.F.1血统从2016-2023年流传,突变可能增强病毒复制和免疫逃避. 加强DENV监测对于及时采取控制措施至关重要.
科学领域:
- 病毒学 病毒学
- 流行病学 流行病学
- 基因组学就是基因组学.
背景情况:
- 登革热病毒 (DENV) 监测对于有效控制和疫苗实施至关重要.
- 了解DENV血清型演变有助于预测和管理疫情.
研究的目的:
- 从2016年到2023年,对斯里兰卡的DENV-2菌株进行鉴定.
- 分析斯里兰卡DENV-2的进化动态和地理传播.
- 为了确定与病毒特征相关的DENV-2的关键突变.
主要方法:
- 使用牛津纳米孔技术对92个DENV-2样本进行测序.
- 在银河系内使用IQ-TREE进行遗传学分析.
- 在封面 (E) 和NS1区域中分析非同义氨基酸变化.
主要成果:
- 2016-2023年的斯里兰卡DENV-2菌株属于基因型II.F.1系.
- 序列显示与南亚和东南亚菌株有密切关系.
- 在E区域确定了15个非同名突变,在NS1区域确定了22个,其中一些与增加的病毒复制和免疫逃避有关.
结论:
- 持续的DENV监测对于跟踪进化模式至关重要.
- 及时识别DENV突变可以为公共卫生干预提供信息.
- 了解病毒进化有助于制定有效的登革热控制策略.
相关概念视频
Viral Mutations
33.0K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
33.0K
Modern Molecular Taxonomy
151
Advancements in molecular biology have revolutionized the identification and characterization of bacteria, with multiple methods leveraging DNA sequencing for enhanced precision. As sequencing technologies improve and costs decline, these approaches are increasingly used in clinical, environmental, and evolutionary studies.Multilocus Sequence Typing (MLST) examines several housekeeping genes, essential chromosomal genes encoding cellular functions, to distinguish strains. Approximately...
151
Single Nucleotide Polymorphisms-SNPs
15.9K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.9K


